Chittagong, Bangladesh (BBN)-The board of directors of Glaxo SmithKline has recommended 550 per cent cash dividend for the year ended on December 31, 2015, said an official disclosure on Thursday.
The final approval will come during the annual general meeting (AGM) scheduled to be held on April 21 at 11:00am at Hotel Peninsula in Chittagong.
The record date is on March 16.
The company has also reported earning per share (EPS) of BDT 68.99, net asset value (NAV) per share of BDT 216.15 and net operating cash flow per share (NOCFPS) of BDT 84.42 for the year ended on December 31, 2015 as against BDT 68.63, BDT 192.30 and BDT 111.14 for the year ended on December 31, 2014, said the disclosure.
There will be no price limit on the trading of the shares of the company today following its corporate declaration.
Wednesday’s closing price of each Glaxo SmithKline share was BDT 1,811.1.
The multinational medicine producer was listed on the Dhaka bourse in 1976.
The company belongs to the “A” category.
The company’s paid-up capital is BDT 120.5 million and authorised capital is BDT 200 million while total number of securities is 12,046,449, according to DSE figures.